Pawar SS, Rasal PB, Kulkarni KH, Pawar SB
A landmark review just published in Frontiers in Toxicology (Karmaus et al., 2026, see comments) systematically compiled replicability data across in vivo guideline studies for the first time
Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% body weight reduction over 48 weeks and significant hepatic fat reduction, supporting research into obesity, NAFLD/MASH, and insulin resistance models
95% CI, 4.3-32.5) and to have improved liver fibrosis (OR, 2.5
Our study confirms more recent findings that opioid receptors are up-regulated in tissue in response to pain, particularly pain associated with inflammation. Ogru said a topical opioid product could eliminate the side effects associated with oral delivery and could be suitable for a number of hard-to-treat pain types such as diabetic neuropathy
Q: What is the shelf life of lyophilized Dihexa